NissensonA.R.Controlling healthcare spending: unintended consequences of a fragmented approach.Adv Ren Replace Therapy1996; 3: (in press).
2.
FriedmanE.A.Rationing of uremia therapy.ArtifOrgans1992; 16: 90–7.
3.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 177–83.
4.
CANADA-USA (CANUSA) Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
5.
KurtinP., NissensonA.R.Variation in end-stage renal disease patient outcomes: What we know, what should we know, and how do we find it out?J Am Soc Nephrol1993; 3: 1738–47.
6.
NissensonA.R.Measuring, managing, and improving quality in the end-stage renal disease treatment setting: peritoneal dialysis.Am J Kidney Dis1994; 24: 368–75.
7.
Su-HernandezL., Abascal-MaciasA., Mendez-BuenoF.J., PaniaguaR., AmatoD.Epidemiologic and demographic aspects of peritoneal dialysis in Mexico.Perit Dial Int1996; 000–00.
8.
NissensonA.R., PrichardS.S., ChengI.K.P., GokalR., KubotaM., MaiorcaR., RiellaM.C., RottembourgJ., StewartJ.H.Non-medical factors that impact on ESRD modality selection.Kidney Int1993; 43(Suppl 40): S120–7.
